Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-01-22

FDA Approved: REPAGLINIDE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved the original application for repaglinide (generic) by Chartwell RX, LLC, making a generic version of this meglitinide-type oral antidiabetic availa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Repaglinide (Repaglinide)

Snippet

ORIG AP for REPAGLINIDE (REPAGLINIDE)